In contrast, Saltari et al. reported that activation of the CD271 intracellular domain by a short β-amyloid-derived peptide (Aβ(25-35)), in combination with chemotherapy or targeted therapy, significantly decreases melanoma metastasis in a zebrafish xenograft model as well as tumor growth in mice [330]. This evidence concerns the gene NGFR and melanoma.